Clinical Trial Update: Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets [Phase 2]

View source ↗

Summary

Phase II trial evaluating overall survival with TheraSphere plus second-line FOLFOX in pancreatic cancer with liver metastases. The study has completed enrollme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Pancreatic Cancer

Drugs mentioned

• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)
• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Liver Cancer, Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-01-06